Get started
Author

S. M. L. Abrams

Observed names: S M Abrams, S M L Abrams, S. M. L. ABRAMS, S. M. Louise Abrams, S. M.L. Abrams, S.M.L. Abrams, SM Abrams
OpenAlex ID: A5037005318
1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial
1989 · Laurence R.I. Baker, S. M. Louise Abrams, et al. · Kidney International · 164
Management of hypertensive crisis: British and Irish Hypertension Society Position document
2022 · Spoorthy Kulkarni, Mark Glover, et al. · Journal of Human Hypertension · 76
PDF
Controlled trial of calcitriol in hemodialysis patients.
1986 · L R Baker, J W Muir, et al. · PubMed · 65
Early therapy of renal bone disease with calcitriol: a prospective double-blind study.
1989 · L R Baker, S M Abrams, et al. · PubMed · 26
Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment
1988 · S M L Abrams, L R I Baker, et al. · Postgraduate Medical Journal · 21
Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction
1994 · M J G Farthing, E M Alstead, et al. · Postgraduate Medical Journal · 20
Influence of debrisoquine hydroxylation phenotype on the pharmacokinetics of mexiletine
1993 · P. Lled�, S. M. L. Abrams, et al. · European Journal of Clinical Pharmacology · 20
The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
1986 · NM Debbas, SH Jackson, et al. · British Journal of Clinical Pharmacology · 14
PDF
Protein binding of indomethacin, methotrexate and morphine in patients with cancer.
1992 · R Raveendran, W M Heybroek, et al. · PubMed · 12
Pharmacokinetics and systemic availability of the antihypertensive agent indoramin and its metabolite 6-hydroxyindoramin in healthy subjects
1987 · D. M. Pierce, S. M. L. Abrams, et al. · European Journal of Clinical Pharmacology · 10
Circadian variation in theophylline absorption during chronic dosing with a slow release theophylline preparation and the effect of clock time of dosing.
1988 · SH Jackson, A Johnston, et al. · British Journal of Clinical Pharmacology · 9
PDF
Aspartame Pharmacokinetics—The Effect of Ageing
1996 · S. PUTHRASINGAM, W. M. HEYBROEK, et al. · Age and Ageing · 8
Effect of indoramin on human sperm motility.
1983 · RB Verma, SM Abrams, et al. · British Journal of Clinical Pharmacology · 7
PDF
Indomethacin and Protein Binding of Methotrexate
1992 · R. Raveendran, W. Heybroek, et al. · Human & Experimental Toxicology · 5
Pharmacokinetic Interaction Between Indoramin and Ethanol
1989 · S.M.L. Abrams, D.M. Pierce, et al. · Human Toxicology · 5
Intra- and inter-subject variation in the pharmacokinetics of indoramin and its 6-hydroxylated metabolite
1988 · D. M. Pierce, S. M. L. Abrams, et al. · European Journal of Clinical Pharmacology · 5
Mexiletine pharmacokinetics and debrisoquine hydroxylator status
1990 · P. Lledo, S.M.L. Abrams, et al. · European Journal of Pharmacology · 3
The effect of indoramin infusion on apparent liver blood flow in man.
1983 · S Hassan, SM Abrams, et al. · British Journal of Clinical Pharmacology · 3
PDF
Controlled trial of calcitriol in the prevention of bone disease in haemodialysed patients.
1983 · V L Sharman, S M Abrams, et al. · PubMed · 2
Pharmacodynamic and pharmacokinetic comparison of two formulations of lorazepam and placebo
1988 · S. M. L. Abrams, T. V. A. Harry, et al. · Human Psychopharmacology Clinical and Experimental · 1
Chemical adherence testing-guided intervention versus standard of care in patients with hypertension who are non-adherent to antihypertensive treatment in the UK (OUTREACH): a multicentre, randomised controlled trial
2026 · Maciej Tomaszewski, Pankaj Gupta, et al. · The Lancet Primary Care
Debrisoquine hydroxylator status in familial adenomatous polyposis
1992 · Pierre‐Marie Lledo, Mansi Patel, et al. · ePrints Soton (University of Southampton)
Book Reviews: Monographs in Clinical Pharmacology 2 Drugs and Renal Disease 2nd edn. Edited by Wm. M. Bennett. Churchill Livingstone, Edinburgh 1986, 206 pp. £21.50
1987 · S.M.L. Abrams · Human Toxicology
Indomethacin does not attenuate the ocular hypotensive effect of timolol.
1985 · QA Mekki, SM Abrams, et al. · British Journal of Clinical Pharmacology
PDF
THE ROLE OF α-ADRENOCEPTOR BLOCKADE IN THE TREATMENT OF HYPERTENSION
1983 · S. M. L. Abrams, P. Turner · Journal of Clinical Pharmacy and Therapeutics
Works count: 27
Citation count: 476
H-index: 10
I10-index: 10
Year
Topic
Type